drugset / Trial / NCT01672606

Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea

NCT01672606

Completed 11 enrolled Malin Jonsson Fagerlund
NaSingle-groupOpen-labelSupportive care

Summary

This study describe the effect of partial neuromuscular blockade of rocuronium on the acute hypoxic ventilatory response in patients with OSA before and after 3 month of CPAP treatment.

Timeline

Start
2012-05
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified Intravenous